We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: Astrocyte protein RTP801 could contribute to cognitive decline in Alzheimer’s illness
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Health > Astrocyte protein RTP801 could contribute to cognitive decline in Alzheimer’s illness
Astrocyte protein RTP801 could contribute to cognitive decline in Alzheimer’s illness
Health

Astrocyte protein RTP801 could contribute to cognitive decline in Alzheimer’s illness

Last updated: May 26, 2025 6:50 pm
Editorial Board Published May 26, 2025
Share
SHARE

Silencing astrocytic RTP801 in 5xFAD mice adjustments purposeful connectivity. Credit score: Alzheimer’s & Dementia (2025). DOI: 10.1002/alz.70051

A analysis workforce on the College of Barcelona’s Institute of Neurosciences (UBneuro) has found new molecular mechanisms associated to the cognitive decline related to Alzheimer’s illness, the most typical dementia. This research, carried out on animal fashions with the illness, describes for the primary time the decisive position of the RTP801 protein in cells generally known as astrocytes through the development of this neurodegenerative illness.

The paper, revealed in Alzheimer’s & Dementia, opens a brand new situation for describing new therapeutic targets within the struggle towards the illness.

The research was carried out by researcher Almudena Chicote and members of the workforce led by Professor Cristina Malagelada, from the UB’s College of Drugs and Well being Sciences and UBneuro, in collaboration with specialists from the UB’s Manufacturing and Validation Middle of Superior Therapies (Creatio), the August Pi i Sunyer Biomedical Analysis Institute (IDIBAPS) and the Biomedical Analysis Networking Middle on Neurodegenerative Ailments (CIBERNED).

RTP801 protein, astrocytes and neurodegeneration

In Alzheimer’s illness, which nonetheless has no treatment, there may be an accumulation of β-amyloid plaques exterior neurons and of hyperphosphorylated tau protein buds inside neurons. The RTP801 protein, encoded by the DDIT4 gene in hippocampal neurons, is concerned within the means of neuroinflammation, neurotoxicity and illness development, as detailed by the workforce in a earlier paper.

As in different illnesses that alter mind operate and trigger cell demise, this pathology entails a fancy interplay between several types of cells within the central nervous system.

Now, the brand new research describes for the primary time the vital position of the RTP801 protein in astrocytes, particular mind cells concerned in neuroinflammation, synaptic regulation and mind homeostasis.

“Astrocytes, previously considered passive support cells, act as active regulators of neurodegenerative processes, including the maintenance of excitatory-inhibitory balance and neuroimmune responses. RTP801 is a stress response protein involved in neuronal dysfunction, but its specific role in astrocytes was not well known,” says Malagelada, from the UB’s Division of Biomedicine and CIBERNED.

Utilizing gene remedy methods, the workforce explored the results of silencing RTP801 protein expression in dorsal hippocampal astrocytes in animal fashions of the illness. The research analyzed the affect of gene silencing on spatial reminiscence, parvalbumin-positive (PV+) interneurons and purposeful mind connectivity, that are interconnected by means of the operate of inhibitory neural circuits.

“In Alzheimer’s disease, dysfunction of these circuits leads to cognitive impairment, emotional dysregulation and disruption of brain network activity, which are key aspects of disease progression. In addition, we also examined its influence on neuroinflammatory markers, specifically astrogliosis, microgliosis and inflammasome activation,” explains first creator of the article Chicote from UBneuro and CIBERNED.

Based on the research, when RTP801 ranges are decreased in astrocytes within the animal mannequin of Alzheimer’s illness, the hyperconnectivity of those mind networks additionally decreases. Due to this fact, normalization of RTP801 expression would assist to revive mind community connectivity much like that of wholesome people.

Metabolic and neural adjustments

The workforce additionally discovered that ranges of GABA—a neurotransmitter important for inhibiting mind excitability—are decreased in animal fashions of Alzheimer’s illness. Nevertheless, this situation may be partially reversed when RTP801 protein expression in astrocytes is silenced. These metabolic adjustments have been linked to the lack of a selected sort of GABA-synthesizing PV+ interneurons within the hippocampus.

“Therefore, silencing the RTP801 protein may help reverse some of the damage to PV+ interneurons in the hippocampus, and this could help restore adequate GABA production and improve brain function,” notes Chicote.

The research additionally means that the aberrant mind community connectivity—the hyperconnectivity or elevated mind community exercise—noticed in some fashions may very well be defined by the toxicity of the RTP801 protein in PV+ neurons within the hippocampus, that are key producers of GABA. “The reduction of RTP801 partially restored these neurons and improved GABA levels,” says the researcher.

The workforce plans to broaden the strains of analysis to strengthen the in vitro findings and validate the usage of RTP801 protein silencing in future therapeutic methods to deal with Alzheimer’s illness.

Extra info:
Almudena Chicote‐González et al, Astrocytes, through RTP801, contribute to cognitive decline by disrupting GABAergic‐regulated connectivity and driving neuroinflammation in an Alzheimer’s illness mouse mannequin, Alzheimer’s & Dementia (2025). DOI: 10.1002/alz.70051

Offered by
College of Barcelona

Quotation:
Astrocyte protein RTP801 could contribute to cognitive decline in Alzheimer’s illness (2025, Could 26)
retrieved 26 Could 2025
from https://medicalxpress.com/information/2025-05-astrocyte-protein-rtp801-contribute-cognitive.html

This doc is topic to copyright. Other than any honest dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is offered for info functions solely.

You Might Also Like

Psilocybin may reverse results of mind accidents ensuing from intimate associate violence, rat research finds

Predicting illness outbreaks utilizing social media

Deep mind stimulation succeeds for 1 in 2 sufferers with treatment-resistant extreme melancholy and nervousness in trial

Australian drug driving deaths have surpassed drunk driving. Here is the way to deal with it

Tooth of infants of confused moms come out earlier, suggests examine

TAGGED:AlzheimersastrocytecognitivecontributedeclinediseaseProteinRTP801
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
How you can Select the Proper Above Floor Pool for Your Yard
Real Estate

How you can Select the Proper Above Floor Pool for Your Yard

Editorial Board May 21, 2025
Dfinity launches Caffeine, an AI platform that builds manufacturing apps from pure language prompts
Consultants publish framework for world adoption of digital well being in medical schooling
White Home seeks to include scandal over Sign chat discussing warfare plans
Publishing C.E.O. Donates $500,000 to Fight Book Bans

You Might Also Like

New malaria drug heralds resistance breakthrough
Health

New malaria drug heralds resistance breakthrough

November 18, 2025
Chasing a successful streak: A brand new approach to set off responses within the physique by simulating psychological strain
Health

Chasing a successful streak: A brand new approach to set off responses within the physique by simulating psychological strain

November 18, 2025
The worldwide system for assessing organ dysfunction in critically sick sufferers is up to date after thirty years
Health

The worldwide system for assessing organ dysfunction in critically sick sufferers is up to date after thirty years

November 18, 2025
Breast most cancers remedies can enhance each survival probabilities and revenue
Health

Breast most cancers remedies can enhance each survival probabilities and revenue

November 18, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • Art
  • World

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?